- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06361173
Spanish BMT4me Usability & Acceptability
April 8, 2024 updated by: Micah Skeens, Nationwide Children's Hospital
The objective of this project is to trans-create, conduct user testing of a previously developed and piloted mHealth app, and user acceptability with parents of children in the acute phase post-allogeneic hematopoietic stem cell transplant (HSCT).
Nationwide Children's Hospital (NCH) will be the primary data collection site and Columbia University Irving Medical Center will be a secondary site.
Study Overview
Study Type
Observational
Enrollment (Estimated)
30
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10027
- Columbia University Irving Medical Center
-
Contact:
- Melissa Beauchemin
- Email: mmp2123@cumc.columbia.edu
-
-
Ohio
-
Columbus, Ohio, United States, 43215
- Nationwide Children's Hospital
-
Contact:
- Bianca Franklin, BS
-
Principal Investigator:
- Micah Skeens, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
This study will recruit 30 self-identified Spanish speaking primary caregivers of children post-HCT at two institutions.
Description
Inclusion Criteria:
Eligible caregivers must have children who:
- Are 0-17 years old
- Underwent HCT
- Are planned for discharge prior to day 100 post-transplant
Primary caregivers must:
- Be Spanish speaking
- Be ≥18 years old
- Have a smartphone (iOS or Android) capable of downloading apps
Exclusion Criteria:
(a) Children or caregivers with pre-existing neurodevelopmental disorder/disability or a pervasive developmental disorder will be excluded from this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Spanish-speaking caregivers
Spanish-speaking caregivers recruited from Nationwide Children's Hospital and Columbia University Irving Medical Center to pilot test a Spanish a transcreated version of the BMT4me app
|
Caregivers will pilot test a Spanish version of the BMT4me app at a single time point.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assess app usability using the System Usability Scale (SUS)
Time Frame: 6/1/24 - 5/1/26
|
Data collected using the System Usability Scale (SUS) will provide insight to the usability of the Spanish BMT4Me app in its current form.
he SUS is a 10-item questionnaire routinely used to evaluate the functionality and acceptability of mHealth apps.
The SUS is scored on a scale, giving a score from from 0 to 100 where 100 is considered the highest rating of usability.
A score of > 68 is considered above average.
|
6/1/24 - 5/1/26
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
June 1, 2024
Primary Completion (Estimated)
May 1, 2026
Study Completion (Estimated)
May 1, 2026
Study Registration Dates
First Submitted
April 2, 2024
First Submitted That Met QC Criteria
April 8, 2024
First Posted (Actual)
April 11, 2024
Study Record Updates
Last Update Posted (Actual)
April 11, 2024
Last Update Submitted That Met QC Criteria
April 8, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00004127
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Aggregate data will be shared upon request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bone Marrow Transplant
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Duke UniversityCompletedBone Marrow Transplant
-
University of Colorado, DenverGlaxoSmithKlineRecruitingStem Cell Transplant | Bone Marrow TransplantUnited States
-
Arizona State UniversityMayo ClinicCompleted
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedBone Marrow TransplantUnited States
-
Mayo ClinicCompletedStem Cell Transplant | Immunosuppression | Bone Marrow TransplantUnited States
-
Stanford UniversityNational Institutes of Health (NIH)WithdrawnBone Marrow Transplant | Hematopoietic Stem Cell Transplant
-
University of Colorado, DenverReimagine CareCompletedBone Marrow TransplantUnited States
-
Stanford UniversityCompletedBone Marrow Transplant | Advance DirectivesUnited States
-
St. Jude Children's Research HospitalCompletedStem Cell Transplant | Bone MarrowUnited States, Canada
-
Children's Hospital Medical Center, CincinnatiAstellas Pharma IncTerminatedCancer | Immunocompromised | Bone Marrow TransplantUnited States
Clinical Trials on BMT4me
-
Micah SkeensNational Institute of Nursing Research (NINR)RecruitingAdherence, Medication | Stem Cell Transplant | Digital HealthUnited States